Testing for COVID-19
There are several viral tests available for detection for COVID-19. For more information on the types of testing available, please visit the CDC’s Testing for COVID-19 webpage. Providers should follow all local, state and federal regulations related to testing, including but not limited to CDPH's COVID-19: Information for Laboratories. Providers may refer patients to our COVID testing, vaccines, and treatment webpage for additional resources.
Prevention
See resources below to learn how providers can prevent COVID-19 in their community.
Promote and encourage vaccination
- Learn how to become a vaccine provider by visiting Vaccine Information for Healthcare Providers.
- The CDC Interim Clinical Considerations provide clinicians with guidance on the use of COVID-19 vaccines currently authorized in the United States.
Keep up to date with local COVID-19 data and regulations
- Stay informed on the latest data by visiting the Respiratory virus data webpage.
- Review the latest COVID-19 policy, including any applicable masking mandates, by visiting the Health Order webpage.
- Review Health Officer guidance for medical professionals by visiting the Health Alerts, Advisories, and Updates webpage.
Promote masking and face coverings
- Encourage others to upgrade their mask. Visit CDPH's When and Why to Wear a Mask webpage for more information.
Review COVID-19 infection prevention measures
- Preventing Spread of Respiratory Viruses When You're Sick (Centers for Disease Control and Prevention)
- Staying Up to Date with COVID-19 Vaccines (Centers for Disease Control and Prevention)
- Infection Control Guidance: SARS-CoV-2 (Centers for Disease Control and Prevention)
- COVID-19 Home Page (California Department of Public Health)
- Best Practices for Ventilation of Isolation Areas to Reduce COVID-19 Transmission Risk in Skilled Nursing Facilities, Long-Term Care Facilities, Hospices, Drug Treatment Facilities, and Homeless Shelters (California Department of Public Health)
COVID-19 treatment
Why prescribe antivirals to treat COVID-19?
COVID-19 therapeutics are a safe and effective measure for preventing severe illness, hospitalization, and death for all persons, especially those at high-risk. All health care providers and prescribers are encouraged to provide therapeutic education and access for patients. See the resources below to learn more about available COVID-19 treatment options.
Provider resources for COVID-19 therapeutics
- Clinicians can find treatment guidelines with evidence-based recommendations on the management of COVID-19 using the following resources:
- COVID-19 Treatment Clinical Care for Outpatients (Centers for Disease Control and Prevention)
- Clinical Course: Progression, Management, and Treatment (Centers for Disease Control and Prevention)
- Types of COVID-19 Treatment (Centers for Disease Control and Prevention)
- COVID-19 Therapeutics (U.S. Department of Health & Human Services Administration for Strategic Preparedness & Response)
- See CDPH’s COVID-19 Treatment Resources for Providers and Facilities for assistance with therapeutics.
- The County of Santa Clara COVID-19 Oral Antivirals webpage provides information on currently authorized COVID-19 oral antiviral medications including eligibility criteria, prescribing instructions, and current pharmacy locations.
- The COVID-19 Therapeutics Transition Guide provides information regarding the transition of COVID-19 therapeutics to the commercial market.
Patient Resources for COVID-19 Therapeutics
- Patients can visit treatments.hhs.gov to find locations with COVID-19 medications, as well as find Test to Treat locations to get assessed for and receive COVID-19 treatment.
- Patients can call (408) 793-7440 or email their name and phone number to [email protected] to discuss oral COVID-19 medication options. All phone consultations are free, though there may be a cost for the medications themselves.
- Patients can visit sesamecare.com/covid or call 1 (833) 686-5051 to make a phone or video appointment to obtain timely COVID-19 oral therapeutics (Paxlovid or Molnupiravir).
- Manufacturers are offering these programs to help eligible patients get the medications for free or low-cost:
- Molnupiravir:
- Patient Assistance Program: Merck Programs - Lagevrio (merckhelps.com) or Tel: 800-727-5400
- Paxlovid:
- Co-Pay Savings Program: Enrollment website for Co-Pay Savings Program
- Patient Assistance Program: PAXCESS Patient Portal or Tel: 1-877-219-7225 (1-877-C19-PACK)
- Molnupiravir:
Reporting
Health care provider reporting is an essential part of the public health response to COVID-19 as the information is used to detect outbreaks, identify exposures in high-risk settings, and inform the allocation of local resources. Timely and complete reporting of fatalities is necessary to characterize and communicate who is at highest risk of dying at home and in the hospital.
- Health care providers who do not provide long-term care may learn about COVID-19 reporting, including how to report and any requirements, by visiting our Report infectious diseases webpage.
- Long-term care providers may visit our Information for long-term care facilities webpage to learn more about their reporting requirements and find reporting resources.
- Health care providers can learn about reporting MIS-C by visiting our Report infectious diseases webpage. All health care providers should fill out the MIS-C Form for all MIS-C cases.